Milan, Italy

Raffaele Tommasini


Average Co-Inventor Count = 5.1

ph-index = 5

Forward Citations = 44(Granted Patents)


Location History:

  • Milan,, IT (1977)
  • Milan, IT (1977 - 1979)

Company Filing History:


Years Active: 1977-1979

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Raffaele Tommasini: Innovator in Pharmaceutical Chemistry

Introduction

Raffaele Tommasini is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. With a total of seven patents to his name, Tommasini's work focuses on innovative solutions for mental health treatments.

Latest Patents

Among his latest patents is the invention of Imidazo[5,1-c][1,4]benzoxazin-1-one, which includes cyclic derivatives of 1,4-benzoxazine and 1,4-benzothiazine. These compounds are recognized for their activity on the central nervous system and function as antidepressant agents. Another significant patent involves novel N-tricyclic derivatives of azetidine, which are useful for their anti-depressant, anti-convulsant, and anxiolytic activities. An illustrative compound from this patent is 1-[5-(10, 11-dihydro-5H-dibenzo [a,d]cyclopheptenyl)]-3-methyl-amino-azetidine.

Career Highlights

Raffaele Tommasini has worked with prominent companies in the pharmaceutical industry, including Carlo Erba S.p.a. and Carlo Erba, S. P. A. His career reflects a commitment to advancing medical science through innovative research and development.

Collaborations

Throughout his career, Tommasini has collaborated with esteemed colleagues such as Piero Melloni and Francesco Lauria. These partnerships have contributed to the successful development of his patented inventions.

Conclusion

Raffaele Tommasini stands out as a significant figure in the realm of pharmaceutical innovations. His contributions to antidepressant compounds highlight the importance of research in improving mental health treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…